Case Report: Concomitant coronary stent and femoral artery thrombosis in the setting of heparin-induced thrombocytopenia [version 1; peer review: 2 approved]
Mejdi Ben Messaoud,
Mezri Maatouk,
Mohamed Mehdi Boussaada,
Marouane Mahjoub,
Walid Mnari,
Habib Gamra
Affiliations
Mejdi Ben Messaoud
Cardiology A Department, Fattouma Bourguiba University Hospital, Monastir, Monastir, Monastir, 5000, Tunisia
Heparin induced thrombocytopenia (HIT) is a rare but potentially life threatening adverse drug reaction. We report an unusual case of concomitant subacute coronary stent and femoral artery thrombosis secondary to HIT. In the current era of extensive growth of heparin use and percutaneous coronary interventions, it’s important for clinicians to remember that such complication might occur and should be prevented.
